Next Generation Sequencing Market to grow at a CAGR of 18.7% by 2026: Top Key Players Thermo Fisher Scientific, Roche, Illumina, QIAGEN, PerkinElmer, Inc., Agilent Technologies Pacific Biosciences , Myriad Genetics , Bio-Rad Laboratories and Eurofins

The Next Generation Sequencing Market Report also provides an analytical assessment of the prime challenges faced by the Market currently, and in the coming years, which helps Market participants in understanding the problems they may face while operating in this Market over a longer period of time.

The Global Next Generation Sequencing market is expected to grow at a CAGR of 18.7% during the forecast period from 2017 to 2026.

Factors such as growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. On the other side, accuracy and standardization issues and lack of skilled labour are inhibiting the market growth. However, rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

SOME OF THE KEY PLAYERS IN GLOBAL NEXT GENERATION SEQUENCING MARKET ARE

• Thermo Fisher Scientific Inc.,

• F. Hoffmann-La Roche AG,

• Illumina, Inc.,

• Beijing Genomics Institute,

• Qiagen N.V.,

• Pacific Biosciences of California, Inc.,

• Perkinelmer, Inc.,

• Agilent Technologies, Inc.,

• Gatc Biotech AG,

• Oxford Nanopore Technologies, Ltd.,

• Macrogen, Inc.,

• Eurofins Scientific,

• Myriad Genetics,

• Bio-Rad Laboratories, Inc.,

• Pieriandx,

• Roche Holding Ag,

• Genomatix Gmbh,

• DNASTAR Inc.,

• Macrogen Inc.

• Helicos BioSciences.

Request Free Sample Copy of the Report @ https://www.researchformarkets.com/sample/next-generation-sequencing-global-market-172050

Next-generation sequencing enables rapid sequencing and produces millions of DNA and RNA sequences. It is otherwise called as massively parallel sequencing technology used in personalized medicines, clinical applications, animal research and other applications.

Depending upon the End Users, the Genetic Screening is a method used to provide important information on gene function as well as the molecular events that underlie a biological process or pathway or identify and select for individuals who possess a phenotype of interest in a mutagenized population. It totally depends on the accuracy of the test, the reliability of the interpretation of the results and the ability to treat the condition based on the quality. Apart from these, it can lessen the anxiety of not knowing the possibility of developing a disease and give a tremendous sense of relief.

By geography, North America is expected to surpass the other regions throughout the forecast period due to the support from various government bodies, like NHGRI (National Human Genome Research Institute, US) and fund research on the genome's structure, function, and role in health and disease.

TYPE OF SEQUENCING COVERED:

• Whole Genome Sequencing

• Targeted Resequencing

• Whole Exome Sequencing

• RNA Sequencing

• CHIP Sequencing

• De Novo Sequencing

• Methyl Sequencing

• Pre-sequencing

PRODUCTS COVERED:

• Instruments

• Reagents & Consumables

• Services

• Platforms

APPLICATIONS COVERED:

• Reproductive Health

• Oncology

• HLA Typing/Immune System Monitoring

• Metagenomics, Epidemiology & Drug Development

• Agrigenomics & Forensics

• Consumer Genomics

• Clinical Investigation

END USERS COVERED:

• Hospitals

• Academics

• Biotech and Pharmaceutical Firms

• Next Generation Sequencing Market By Application

• Drug Discovery/Personalized Medicine

• Genetic Screening

• Diagnostics/Infectious Diseases

• Agriculture and Animal Research

• Other End Users

Request for Report Brochure for Latest Industry Insights @ https://www.researchformarkets.com/reports/next-generation-sequencing-global-market-172050

MAJOR CHAPTERS COVERED IN NEXT GENERATION SEQUENCING MARKET RESEARCH ARE:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 By Type of Sequencing

6 By Product

7 By Application

8 By End User

9 By Geography

10 Key Developments

11 Company Profiling

What Our Report Offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic recommendations for the new entrants

- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets

- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements

Customization Options

• All segmentation provided above in this report is represented at country level and can be customized according to needs.

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).

Reasons to Purchase this Report

· Current and future of global oncology nutrition market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

· Regions/countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Inquiry Before Buying@ https://www.researchformarkets.com/inquiry/next-generation-sequencing-global-market-172050

About Research for Markets:

Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Contact:

Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: alan.naidu@researchformarkets.com

This release was published on openPR.